# US 2012/0253380 A1 · Balloon for the treatment of stenosis and method for manufacturing the balloon

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253380 A1
- Document ID: US20120253380A1
- Status: Published application
- Kind: A1
- Application number: 12/744,308
- Filed: 2007-11-21
- Published: 2012-10-04
- Earliest claimed: 2007-11-21
- Assignees: Invatec S.r.l.
- Inventors: Andrea Venturelli
- Web page: https://patentgrep.com/patent/US20120253380A1

## CPC

- A61M 25/104: {used for angioplasty}
- A61F 2/958: Inflatable balloons for placing stents or stent-grafts
- A61M 25/1002: {characterised by balloon shape (A61M25/1006, A61M25/1009 take precedence)}
- A61M 25/1011: {Multiple balloon catheters}
- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61M 2025/0057: {Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings}
- A61M 2025/1004: {Balloons with folds, e.g. folded or multifolded}
- A61M 2025/1013: {with concentrically mounted balloons, e.g. being independently inflatable}
- A61M 2025/105: {having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The present invention relates to a balloon (1) for treating stenosis and the method for obtaining this balloon. The method comprises the steps of: bringing the balloon in the deployed configuration; placing a plurality of stylets (17) that are arranged in the axial direction along the outer wall (10) of the balloon; pushing the stylets towards the balloon core (11) in the radial direction such as to form a plurality of laps (12); laying the laps about the core in the tangential direction such as to lay each lap on an adjacent stylet; removing the stylets such as to form a plurality of cavities (13) comprised between each lap and the balloon core; filling the cavities with the drug.

## Claims

### Claim 1

A balloon for angioplasty suitable to adopt a deployed configuration and a collapsed configuration, having an outer wall and a core defining an axis, the balloon comprising in the collapsed configuration a plurality of laps that are laid in a tangential direction about the core of the balloon such as to form a plurality of cavities, wherein the cavities are filled with a drug.

### Claim 2 (depends on 1)

The balloon according to claim 1 wherein, in the collapsed configuration, the balloon is suitable to be inserted within the circulatory system of a patient's body and to be advanced along the vessels to reach a vessel section that is affected by stenosis.

### Claim 3 (depends on 1)

The balloon according to claim 1 wherein, when the balloon passes from the collapsed configuration to the deployed configuration, it is suitable to apply a radial force to a stenosis such as to expand the latter and restore the nominal section of a patient's blood vessel.

### Claim 4 (depends on 1)

The balloon according to claim 1 wherein, in the deployed configuration, the balloon comprises a plurality of bands of drug that are axially arranged along the outer wall.

### Claim 5 (depends on 4)

The balloon according to claim 4 wherein the bands of drug are alternated in the circumferential direction with strips in which the drug is not provided, and the outer wall is directly exposed.

### Claim 6 (depends on 4)

The balloon according to claim 4 wherein the bands of drug are about twice wider than the strips.

### Claim 7 (depends on 4)

The balloon according to claim 4 wherein the bands are equally spaced from each other in the circumferential direction along the outer wall of the balloon.

### Claim 8 (depends on 5)

The balloon according to claims 5 wherein, when the balloon is in the collapsed configuration, the drug is protected by the laps i.e. the drug is not exposed to contact with the external environment and only the strips of wall that is not covered with drug are exposed.

### Claim 9 (depends on 1)

The balloon according to claim 1 wherein the drug is lipophilic.

### Claim 10 (depends on 1)

The balloon according to claim 1 wherein the drug comprises an anti-tumour active ingredient suitable to be employed as an antiproliferative and a suitable excipient.

### Claim 11 (depends on 1)

The balloon according to claim 1 wherein the drug contains Rapamycin, Epothilone or preferably Paclitaxel as the active ingredient.

### Claim 12 (depends on 9)

The balloon according to claim 9 wherein the excipient is a gel or paste suitable to penetrate within the cavities and adhere to the wall of the balloon.

### Claim 13 (depends on 1)

The balloon according to claim 1 further comprising containment means to be capable of stopping the blood flow in the length where the angioplasty operation has to be carried out.

### Claim 14 (depends on 13)

The balloon according to claim 13 wherein the containment means are capable of avoiding the washing effect in the blood flow, which tends to remove and disperse the drug immediately after the application by means of the balloon.

### Claim 15 (depends on 13)

The balloon according to claim 13 wherein the containment means comprise an auxiliary balloon that is placed in an immediately distal position relative to the balloon.

### Claim 16 (depends on 13)

The balloon according to claim 13 wherein the containment means comprise two auxiliary balloons that are placed in immediately proximal and immediately distal positions relative to the balloon.

### Claim 17 (depends on 15)

The balloon according to claim 15 wherein the auxiliary balloons are suitable to pass from a collapsed configuration with minimum radial overall dimensions, to a deployed configuration in which they are suitable to come in contact with the walls of a blood vessel such as to stop the blood flow.

### Claim 18 (depends on 15)

The balloon according to claim 15 wherein the auxiliary balloons are not suitable to apply the radial force that is required for the angioplasty operation.

### Claim 19 (depends on 13)

The balloon according to claim 13 wherein the containment means comprise two shaped portions of the balloon.

### Claim 20 (depends on 19)

The balloon according to claim 19, wherein the shaped portions are obtained as one piece with the balloon and are connected to the ends, distal and proximal of the balloon, respectively.

### Claim 21 (depends on 19)

The balloon according to claim 19 wherein the balloon is capable of adopting:
a collapsed configuration with minimum radial overall dimensions;
a deployed configuration in which it has maximum overall dimensions and is suitable to apply a radial force sufficient to bring the angioplasty operation to completion;
a semi-deployed configuration, in which the shaped portions maintain the maximum radial overall dimensions, whereas the central length of the balloon adopts intermediate radial overall dimensions.

### Claim 22 (depends on 1)

The balloon according to claim 1 further comprising a stent being fitted on the balloon.

### Claim 23

A catheter for angioplasty comprising a balloon for angioplasty suitable to adapt a deployed configuration and a collapsed configuration, said balloon having an outer wall and a core defining an axis, the balloon comprising in the collapsed configuration a plurality of laps that are laid in a tangential direction about the core of the balloon so as to form a plurality of cavities, wherein the cavities are filled with a drug.

### Claim 24 (depends on 23)

The catheter according to claim 23 wherein the balloon is mounted to the distal end of the catheter.

### Claim 25

A method for arranging a drug on an angioplasty balloon, the balloon being suitable to adopt a deployed configuration and a collapsed configuration, having an outer wall and a core defining an axis, the balloon comprising in the collapsed configuration a plurality of laps that are laid in the tangential direction about the core, the method comprising the steps of:
arranging the balloon in the collapsed configuration;
placing a plurality of stylets being arranged in an axial direction between each lap and the core of the balloon;
pressing the laps in the radial direction on the core such as to match each lap with the underlying stylet;
removing the stylets such as to form a plurality of cavities comprised between each lap and the core of the balloon;
filling the cavities with the drug.

### Claim 26 (depends on 25)

The method according to claim 25, wherein the step of placing the stylets between each lap and the core of the balloon, comprises the following steps:
bringing the balloon in the deployed configuration;
placing a plurality of stylets being arranged in the axial direction along the outer wall of the balloon;
pushing the stylets in the radial direction towards the core of the balloon such as to form a plurality of laps;
laying the laps in the tangential direction about the core such as to lay each lap on a adjacent stylet;
bringing back the balloon in the collapsed configuration.

### Claim 27 (depends on 25)

The method according to claim 25, wherein during the step of filling the cavities with the drug, the balloon is wrapped in a protective sheath for maintaining the laps in position.

### Claim 28 (depends on 25)

The method according to claim 25 wherein the drug is dripped within the cavities that are formed when the stylets are removed.

### Claim 29 (depends on 25)

The method according to claim 25, wherein the stylets are hollow and are suitable to deliver the drug that is intended to fill the cavities.

### Claim 30 (depends on 29)

The method according to claim 29, wherein during the step of removing the stylets, from the end of each stylet a volume of drug is delivered, which is suitable to fill the cavity which is formed as the stylet is being removed.

### Claim 31 (depends on 25)

The method according to claims 25, wherein the drug is sucked within the cavities by applying a depressurization.

### Claim 32 (depends on 25)

The method according to claim 25, further comprising the step of fitting a stent on the balloon.
